|
|
|
|
|
Legal status
Patent in force
| (51) | INT.CL. | A61K 38/08 | (2019.01) |
| C07K 7/06 | (2006.01) | ||
| A61P 3/14 | (2006.01) | ||
| A61P 5/20 | (2006.01) | ||
| A61P 5/00 | (2006.01) |
| (11) | Number of the document | 3192520 |
| (13) | Kind of document | T |
| (96) | European patent application number | 16190682.1 |
| Date of filing the European patent application | 2010-07-29 | |
| (97) | Date of publication of the European application | 2017-07-19 |
| (45) | Date of publication and mention of the grant of the patent | 2019-03-06 |
| (46) | Date of publication of the claims translation | 2019-06-25 |
| (30) | Number | Date | Country code |
| 229695 P | 2009-07-29 | US | |
| 255816 P | 2009-10-28 | US | |
| 313635 P | 2010-03-12 | US |
| (72) |
KARIM, Felix, US
BARUCH, Amos, US
MACLEAN, Derek, US
DAS, Kanad, US
YIN, Qun, US
|
| (73) |
KAI Pharmaceuticals, Inc.,
270 Littlefield Avenue, South San Francisco CA 94080,
US
|
| (74) |
Liudmila GERASIMOVIČ,
IĮ "Liudmila Gerasimovič, Patentinis patikėtinis", Vingrių g. 13-42, LT-01141 Vilnius,
LT
|
| (54) | Terapiniai agentai, skirti paratiroidinio hormono lygių sumažinimui |
| THERAPEUTIC AGENTS FOR REDUCING PARATHYROID HORMONE LEVELS |
| Payment date | Validity (years) | Amount | |
| 2025-06-19 | 16 | 347.00 EUR |
| 2026-07-29 |